The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2021 | Reframing how to define success in SCD
Alan Anderson, MD, Prisma Health, Columbia, SC, talks on the current challenges of treating sickle cell disease (SCD). In the US, the biggest challenge is reframing how to define success in SCD. Currently, there are tools available that can modify the disease at younger ages and improve the disease outcomes and reduce disability as patients get older. Dr Anderson also highlights the importance of the destigmatization of the disease and how this is a global issue. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
